Risk and outcomes of COVID‐19 in patients with multiple sclerosis-Reference-Cited by-同舟云学术

Risk and outcomes of COVID‐19 in patients with multiple sclerosis

Published:2021-07-18 Issue:11 Volume:28 Page:3712-3721
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Moreno‐Torres Irene¹,Meca Lallana Virginia²^ORCID,Costa‐Frossard Lucienne³,Oreja‐Guevara Celia⁴,Aguirre Clara²,Alba Suárez Elda María⁵,Gómez Moreno Mayra⁶^ORCID,Borrega Canelo Laura⁷,Sabín Muñoz Julia⁸,Aladro Yolanda⁹,Cárcamo Alba⁹,Rodríguez García Elena¹⁰,Cuello Juan Pablo¹¹,Monreal Enric³,Sainz de la Maza Susana³,Pérez Parra Fernando¹²,Valenzuela Rojas Francisco¹³,López de Silanes de Miguel Carlos¹⁴,Casanova Ignacio¹⁴,Martínez Gines Maria Luisa¹¹,Blasco Rosario⁸,Orviz García Aida¹,Villar‐Guimerans Luisa María³,Fernández‐Dono Guillermo¹⁵,Elvira Víctor¹⁶,Santiuste Carmen³,Espiño Mercedes³,García Domínguez José Manuel¹¹^ORCID

Affiliation:

1. Demyelinating Diseases Unit Jiménez Diaz Foundation University Hospital Madrid Spain

2. Demyelinating Diseases Unit La Princesa University Hospital Madrid Spain

3. Multiple Sclerosis Unit Ramón y Cajal University Hospital Madrid Spain

4. Department of Neurology Department of Medicine Faculty of Medicine San Carlos Clinical Hospital Complutense University of Madrid and San Carlos Institute for Health Research Madrid Spain

5. Neuroimmunology and Multiple Sclerosis Unit La Paz University Hospital Madrid Spain

6. Infanta Leonor University Hospital Madrid Spain

7. Alcorcón Foundation University Hospital Madrid Spain

8. Neuroimmunology Unit Puerta de Hierro University Hospital Madrid Spain

9. Demyelinating Diseases Unit University Hospital of Getafe Madrid Spain

10. Severo Ochoa University Hospital Madrid Spain

11. Demyelinating Diseases Unit Gregorio Marañón General University Hospital Madrid Spain

12. Henares University Hospital Madrid Spain

13. Central Defense Hospital "Gómez Ulla," Madrid Spain

14. Torrejón University Hospital Madrid Spain

15. Complutense University of Madrid Madrid Spain

16. University of Edinburgh Edinburgh Scotland

Funder

Merck

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14990

Reference33 articles.

1. Infection Risk in Patients on Multiple Sclerosis Therapeutics

2. Predictors of hospitalization in a Canadian MS population: A matched cohort study

3. All‐cause hospitalizations in multiple sclerosis patients;Maia C;Rev Neurol,2019

4. Hospital admissions and MS: temporal trends and patient characteristics;Evans C;Am J Manag Care,2012

5. World Health Organization.Seasonal influenza factsheets.http://www.who.int/mediacentre/factsheets/fs211/en/.2018. Accessed June 22 2020.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Risk Classification For Severe COVID-19 Based On Chronic Medical Conditions: A Comparative Analysis;2024-09-06

2. Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease‐modifying treatment;European Journal of Neurology;2024-04-19

3. Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort;Vaccines;2024-03-03

4. Risk of MS relapse and deterioration after COVID-19: A systematic review and meta-analysis;Multiple Sclerosis and Related Disorders;2024-03

5. Accelerated Course of Cerebral Adrenoleukodystrophy After Coronavirus Disease 2019 Infection;Pediatric Neurology;2024-03